IL-6 Signaling and its Blockade with a Humanized Anti-Interleukin-6 Receptor Antibody in Rheumatoid Arthritis: Advent of a New and Innovative Therapeutic Drug, Tocilizumab

By  

Current Rheumatology Reviews, Vol. 7, Iss. 4, 2011-11 ,pp. : 288-300

Bentham Science Publishers

Access to resources Recommend Favorite

Interleukin-6 receptor inhibition with tocilizumab in various renal involvements associated with multicentric Castleman's disease: areportofthree cases

By Komaba Hirotaka   Nakazawa Takashi   Yamaguchi Yutaka   Kumagai Shunichi   Fukagawa Masafumi  

NDT PLUS, Vol. 1, Iss. 6, 2008-12 ,pp. : 423-426

Oxford University Press

Access to resources Recommend Favorite

Clinical evaluation of tocilizumab for patients with active rheumatoid arthritis refractory to anti-TNF biologics: tocilizumab in combination with methotrexate

By Nakashima Yasuharu   Kondo Masakazu   Harada Hiroshi   Horiuchi Takahiko   Ishinishi Takashi   Jojima Hiroshi   Kuroda Koji   Miyahara Hisaaki   Nagamine Ryuji   Nakashima Hitoshi   Otsuka Takeshi   Saikawa Isao   Shono Eisuke   Suematsu Eiichi   Tsuru Tomomi   Wada Ken   Iwamoto Yukihide  

Modern Rheumatology, Vol. 20, Iss. 4, 2010-08 ,pp. : 343-352

Springer Publishing Company

Access to resources Recommend Favorite

Necrotizing fasciitis in a patient with rheumatoid arthritis treated with tocilizumab

By Yoshida Akiko  

Modern Rheumatology, Vol. 22, Iss. 2, 2012-04 ,pp. : 317-318

Springer Publishing Company

Access to resources Recommend Favorite

Tocilizumab: a new form of biological therapy for rheumatoid arthritis

By Balint Geza P   Balint Peter V  

Future Rheumatology, Vol. 2, Iss. 4, 2007-08 ,pp. : 361-371

Future Medicine

Access to resources Recommend Favorite